The effect of the IRA on our business and the healthcare industry in general is not yet known.
All entries for: Fulcrum Therapeutics, Inc.
February 24, 2026
Fulcrum Therapeutics, Inc.
Neutral Outlook
Cambridge, MA
51-200 employees
in May 2025, the current U.S. administration published Executive Order 14297, “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” which generally, among other things, directs the federal government to establish and communicate most-favored-nation, or MFN, price targets to pharmaceutical manufacturers to bring prices for U.S. patients in line with comparably developed nations.
February 24, 2026
Fulcrum Therapeutics, Inc.
Neutral Outlook
Cambridge, MA
51-200 employees
The effects of the IRA on our business and the healthcare industry in general are not yet known.
Disease Area: Hematology, Multiple, Neurological Diseases, Rare Diseases
Drug Type: Small Molecule